Aytu Biopharma (AYTU) Work In Process (2021 - 2026)
Aytu Biopharma's Work In Process came in at $2.33 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 68.6% from $1.38 million a year earlier and up 13.8% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Work In Process (2021 - 2026) Analysis & Trends
Going back to fiscal Q3 2021, Aytu Biopharma's Work In Process data covers 22 quarters.
- Work In Process carries a five-year compound annual growth rate of -7.0% (FY2021 to FY2026).
- Going back by fiscal year, Work In Process was $1.38 million in FY2025 (-75.9%), $5.73 million in FY2024 (+93.7%), $2.96 million in FY2023 (+60.8%) and $1.84 million in FY2022 (-45.1%).
- The fiscal Q4 2026 figure represents the highest quarterly Work In Process since fiscal Q2 2025.
- Year-over-year, Work In Process increased in three of the last eight quarters, with an average decline of 20.5%.
- The fastest year-over-year change in Work In Process over five years came in fiscal Q4 2024 (growth of 93.7%), and the weakest in fiscal Q4 2025 (a decline of 75.9%).
- Business Quant data shows AYTU's Work In Process at $2.05 million (Q3 2026), $1.82 million (Q2 2026) and $862,000 (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.33 Mn |
| Mar 31, 2026 | 2.05 Mn |
| Dec 31, 2025 | 1.82 Mn |
| Sep 30, 2025 | 862,000.00 |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 3.10 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Jun 30, 2024 | 5.73 Mn |
| Mar 31, 2024 | 5.02 Mn |
| Dec 31, 2023 | 2.67 Mn |
| Sep 30, 2023 | 3.29 Mn |
| Jun 30, 2023 | 2.96 Mn |
| Mar 31, 2023 | 2.82 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Sep 30, 2022 | 2.37 Mn |
| Jun 30, 2022 | 1.84 Mn |
| Mar 31, 2022 | 2.22 Mn |
| Dec 31, 2021 | 2.17 Mn |
| Sep 30, 2021 | 3.01 Mn |
API Access
Aytu Biopharma Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();